Brussels, July 2025 — The European Union is stepping up its resilience in the face of future pandemics. This week, EU authorities announced the creation of a strategic stockpile of critical medical products designed to enable rapid response to public health emergencies such as pandemics or industrial disasters.
A European “health shield” in progress
The initiative, led by the European Health Emergency Preparedness and Response Authority (HERA), will include reserves of vaccines, treatments, diagnostics, personal protective equipment (PPE), and other essential medical supplies across several member states.
This “health shield” is designed to prevent the shortages experienced during the COVID-19 pandemic and ensure a coordinated EU-wide response.
“We must never be caught unprepared again. With this strategic reserve, we’ll be able to respond faster, more efficiently, and better protect our citizens,” said a European Commission spokesperson.
Increased funding through 2027
To support this project, HERA will receive €200 million in funding by 2027, through the EU Health Programme. The funds will be used to purchase medical supplies, modernize storage and distribution infrastructure, and improve the supply chain across Europe.
Lessons learned from the pandemic
COVID-19 exposed Europe’s heavy reliance on foreign suppliers for essential items such as masks, gloves, and testing equipment. With this new system, the EU aims to achieve greater strategic autonomy while encouraging local innovation and production.
A strategy welcomed by experts
Many public health experts have praised this announcement, calling it a major step toward European health sovereignty and possibly a model for other regions of the world.
